The pandemic fundamentally altered how expectant mothers with high blood pressure access healthcare, revealing both opportunities and disparities that persist today. This transformation matters because pregnancy-related hypertension affects up to 10% of pregnancies and requires careful monitoring to prevent life-threatening complications like preeclampsia.
Analyzing over one million deliveries across 28 US health systems, researchers found that telehealth adoption among pregnant women with hypertension jumped from 0.24% before COVID-19 to nearly 27% by 2022-2023. The increase was even more dramatic than among pregnant women without hypertension, who saw telehealth use rise from 0.2% to 16.4%. Among the 108,606 deliveries involving hypertensive pregnancies, telehealth became a primary care modality rather than an emergency substitute.
This shift represents a potential revolution in maternal care delivery, particularly valuable for high-risk pregnancies requiring frequent blood pressure monitoring and medication adjustments. Remote consultations could reduce travel burdens while maintaining essential oversight during vulnerable pregnancy stages. However, the data reveals concerning access gaps: Hispanic women with pregnancy hypertension used telehealth at significantly lower rates than Black or white women, suggesting digital health disparities that could worsen maternal outcomes.
The persistence of elevated telehealth usage into 2022-2023 indicates this isn't merely a pandemic artifact but likely a permanent healthcare evolution. For maternal health, this could mean more accessible specialist consultations and continuous monitoring. Yet the technology's full potential remains unrealized without addressing the ethnic disparities that could leave the most vulnerable mothers behind in this digital transformation.